AU2001296915A1 - Inhibition of antigen presentation with poorly catabolized polymers - Google Patents
Inhibition of antigen presentation with poorly catabolized polymersInfo
- Publication number
- AU2001296915A1 AU2001296915A1 AU2001296915A AU9691501A AU2001296915A1 AU 2001296915 A1 AU2001296915 A1 AU 2001296915A1 AU 2001296915 A AU2001296915 A AU 2001296915A AU 9691501 A AU9691501 A AU 9691501A AU 2001296915 A1 AU2001296915 A1 AU 2001296915A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibition
- polymers
- antigen presentation
- poorly catabolized
- catabolized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000030741 antigen processing and presentation Effects 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23532100P | 2000-09-26 | 2000-09-26 | |
US60/235,321 | 2000-09-26 | ||
PCT/US2001/042329 WO2002026240A2 (en) | 2000-09-26 | 2001-09-25 | Inhibition of antigen presentation with poorly catabolized polymers |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296915A1 true AU2001296915A1 (en) | 2002-04-08 |
Family
ID=22885010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296915A Abandoned AU2001296915A1 (en) | 2000-09-26 | 2001-09-25 | Inhibition of antigen presentation with poorly catabolized polymers |
Country Status (4)
Country | Link |
---|---|
US (3) | US7538097B2 (en) |
AU (1) | AU2001296915A1 (en) |
CA (1) | CA2460042C (en) |
WO (1) | WO2002026240A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001296915A1 (en) * | 2000-09-26 | 2002-04-08 | Sidney Kimmel Cancer Center | Inhibition of antigen presentation with poorly catabolized polymers |
WO2006096164A1 (en) | 2005-03-03 | 2006-09-14 | Allergan, Inc. | Media for clostridium bacterium and processes for obtaining a clostridial toxin |
ES2520765T3 (en) * | 2007-02-15 | 2014-11-11 | Allergan, Inc. | Use of botulinum toxin for the treatment of hyperhidrosis |
TWI489994B (en) * | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
IL88554A0 (en) * | 1988-12-01 | 1989-07-31 | Hadassah Med Org | Compositions containing a compound binding to a heparin receptor |
FR2651436B1 (en) * | 1989-09-05 | 1994-09-09 | Sanofi Sa | PHARMACEUTICAL COMPOSITIONS CONTAINING A SOLUBLE DEXTRAN SUBSTITUTED DERIVATIVE. |
FR2657782B1 (en) * | 1990-02-06 | 1992-05-22 | Therapeutiques Substitutives | NEW ANTITUMOR AGENT DERIVED FROM DEXTRANE. |
FR2718026B1 (en) * | 1994-03-30 | 1997-01-17 | Paris Val Marne Universite | Medicine and pharmaceutical composition for the treatment of muscles. |
JP4435412B2 (en) * | 1997-12-09 | 2010-03-17 | バイオメディカル・フロンティアーズ・インコーポレイテッド | Modified polysaccharides exhibiting modified biological recognition |
FR2794976B1 (en) * | 1999-06-16 | 2004-05-07 | Solutions | PHARMACEUTICAL COMPOSITIONS WITH HEALING OR ANTI-COMPLEMENTARY ACTION COMPRISING A DEXTRANE DERIVATIVE |
US20030212021A1 (en) * | 2001-01-25 | 2003-11-13 | Frost Gregory I. | Myeloid colony stimulating factor and uses thereof |
AU2001296915A1 (en) * | 2000-09-26 | 2002-04-08 | Sidney Kimmel Cancer Center | Inhibition of antigen presentation with poorly catabolized polymers |
-
2001
- 2001-09-25 AU AU2001296915A patent/AU2001296915A1/en not_active Abandoned
- 2001-09-25 WO PCT/US2001/042329 patent/WO2002026240A2/en active Application Filing
- 2001-09-25 CA CA2460042A patent/CA2460042C/en not_active Expired - Fee Related
- 2001-09-25 US US10/381,855 patent/US7538097B2/en not_active Expired - Fee Related
-
2009
- 2009-05-08 US US12/463,315 patent/US7786096B2/en not_active Expired - Fee Related
-
2010
- 2010-08-31 US US12/872,620 patent/US20100331279A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002026240A9 (en) | 2003-02-06 |
CA2460042A1 (en) | 2002-04-04 |
CA2460042C (en) | 2012-05-08 |
US7538097B2 (en) | 2009-05-26 |
WO2002026240A2 (en) | 2002-04-04 |
US20040047874A1 (en) | 2004-03-11 |
US20090215722A1 (en) | 2009-08-27 |
WO2002026240A3 (en) | 2002-06-06 |
US7786096B2 (en) | 2010-08-31 |
US20100331279A1 (en) | 2010-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001286677A1 (en) | Controlled release of substances | |
AU2001258771A1 (en) | -secretase inhibitors | |
AU2002359841A1 (en) | Paired expandable anastomosis device | |
AU2001264898A1 (en) | Ureteral stent | |
AU2001293032A1 (en) | Method for determining the frictional properties of materials | |
AU2001275007A1 (en) | Methods of testing materials | |
AU2002222627A1 (en) | Tak1 inhibitors | |
AU2002211370A1 (en) | Inhibition of tgf-beta and uses thereof | |
AU2002228642A1 (en) | Footing form | |
AU2001267428A1 (en) | Direct detection of individual molecules | |
AU2001232948A1 (en) | Controlled release of drugs | |
AUPR110100A0 (en) | Improved separation of macromolecules | |
AU2001273457A1 (en) | Foamed-thermoplastic films | |
AU2001275287A1 (en) | Polymerization inhibitor for vinyl-containing materials | |
AU2001229530A1 (en) | Detection of fermentation-related microorganisms | |
AU2001255754A1 (en) | Methods and compositions for the manufacture of molecular beacons | |
AU3724701A (en) | Family 5 xyloglucanases | |
AU2001296915A1 (en) | Inhibition of antigen presentation with poorly catabolized polymers | |
AU2002214038A1 (en) | Inhibitors of transglutaminases | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001251004A1 (en) | Detection of viable agents | |
AU2001258659A1 (en) | Improved methods of transfection | |
AU2002366341A1 (en) | Polymerization of alpha-methylstyrene | |
AU2001234254A1 (en) | Wall | |
AU2001228647A1 (en) | Dihydrofolate reductase inhibitors |